Prof Meg Jardine is Director of the NHMRC Clinical Trials Centre at University of Sydney, Camperdown, AU.
She is a member of the International Society of Nephrology Executive Committee (2023 – 2025), an Executive Committee member of the international nephrology guidelines body, KDIGO, and has contributed to Australian CARI guideline development.
Prof Jardine's research focusses on reducing the progression and complications of non-communicable diseases, particularly kidney disease, diabetes and cardiovascular disease, through randomised trials and epidemiological analyses.
